Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study.
| Autor: | Satoshi Shinozaki1,2 shinozaki-s@aqua.ocn.ne.jp, Toshiyuki Tahara3, Lefor, Alan Kawarai4, Ogura, Masahito5 |
|---|---|
| Zdroj: | Clinical & Experimental Hepatology. 2021, Vol. 7 Issue 2, p172-177. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|